CRLBF
Cresco Labs Inc.1.7540
+0.4540+34.9%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
M&A pipeline details, pricing stabilization
Q&A unpacked a robust M&A pipeline driven by operators exiting amid high capital costs and regulatory clarity, beyond just distressed assets—now including partnerships for densification. Data from 500k+ loyalty members and 75% digital sales sharpens retail pricing and first-party shifts, sustaining margins. Germany pilot scales modestly with reinvested profits; pricing stabilizes better than expected, eyeing H2 relief from consolidation, premium mix, and hemp curbs. New York impairment reflects structural challenges, muting wholesale penetration versus other opps. Answers largely reaffirmed prepared margin progress. M&A execution matters next.
Key Stats
Market Cap
626.91MP/E (TTM)
-Basic EPS (TTM)
-0.16Dividend Yield
0%IPO
Website
Employees
Sector
Industry
ACB
Aurora Cannabis Inc.
5.53+0.41
CBDL
CBD Life Sciences Inc.
0.00+0.00
CRON
Cronos Group Inc. Common Share
3.16+0.11
CURLF
Curaleaf Holdings, Inc.
4.53+0.85
CWBHF
Charlotte's Web Holdings Inc.
0.15+0.00
GHBWF
-
0.71+0.09
GTBIF
Green Thumb Industries Inc.
9.63+1.23
INCR
Intercure Ltd.
1.45+0.05
LEEEF
LEEF BRANDS INC
0.22+0.02
MRMD
MariMed Inc.
0.12+0.01